INS and metabolic dysfunction-associated steatotic liver disease: They also increase adiponectin levels, enhance glucose tolerance and insulin sensitivity, improve dyslipidemia, and lower blood pressure in patients with non-alcoholic fatty liver disease (NAFLD) [19].